Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45753cecc639997fe19d195ad3d6a74a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-22022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-645 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
filingDate |
2000-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ac221ac69b3cb3eb763a4fb226d395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4563c11db2d8424ad277f018181c776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c64d86c43a1e97e6057f83dbfed27d0 |
publicationDate |
2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1586582-A1 |
titleOfInvention |
Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
abstract |
The invention relates to a synthetic biologically activenMolecule for anchoring a drug to virus protein 1n(VP1) of the polyoma virus, with one from the C-terminal end of thenVirus protein 2 (VP2) or 3 (VP3) derived from the polyoma virusnAmino acid sequence A1 at one end with anActive substance is connected. |
priorityDate |
1999-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |